BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 16443680)

  • 1. Development of CD4+ T cells expressing a nominally MHC class I-restricted T cell receptor by two different mechanisms.
    Ge Q; Holler PD; Mahajan VS; Nuygen T; Eisen HN; Chen J
    Proc Natl Acad Sci U S A; 2006 Feb; 103(6):1822-7. PubMed ID: 16443680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4+ T cells mature in the absence of MHC class I and class II expression in Ly-6A.2 transgenic mice.
    Henderson SC; Berezovskaya A; English A; Palliser D; Rock KL; Bamezai A
    J Immunol; 1998 Jul; 161(1):175-82. PubMed ID: 9647222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymic development in human CD4 transgenic mice. Positive selection occurs after commitment to the CD8 lineage.
    Paterson RK; Burkly LC; Kurahara DK; Dunlap A; Flavell RA; Finkel TH
    J Immunol; 1994 Oct; 153(8):3491-503. PubMed ID: 7930572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantigen-independent deletion of diabetogenic CD4+ thymocytes by protective MHC class II molecules.
    Schmidt D; Amrani A; Verdaguer J; Bou S; Santamaria P
    J Immunol; 1999 Apr; 162(8):4627-36. PubMed ID: 10202002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in CD4-binding regions of the MHC class II molecule I-Ek do not impede CD4+ T cell development.
    Yelon D; Schaefer KL; Berg LJ
    J Immunol; 1999 Feb; 162(3):1348-58. PubMed ID: 9973389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual MHC class I and class II restriction of a single T cell receptor: distinct modes of tolerance induction by two classes of autoantigens.
    Arsov I; Vukmanović S
    J Immunol; 1999 Feb; 162(4):2008-15. PubMed ID: 9973472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage-dependent reactivity of thymocytes to self-peptide--MHC complexes.
    Leng Q; Ge Q; Nguyen T; Eisen HN; Chen J
    Proc Natl Acad Sci U S A; 2007 Mar; 104(12):5038-43. PubMed ID: 17360333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Coreceptor function of CD4 in response to MHC class I molecule].
    Zvezdova ES; Grinenko TS; Pobezinskaia EL; Pobezinskiĭ LA; Kazanskiĭ DB
    Mol Biol (Mosk); 2008; 42(4):662-72. PubMed ID: 18856067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective development of CD4+ T cells in transgenic mice expressing a class II MHC-restricted antigen receptor.
    Kaye J; Hsu ML; Sauron ME; Jameson SC; Gascoigne NR; Hedrick SM
    Nature; 1989 Oct; 341(6244):746-9. PubMed ID: 2571940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced T cell maturation and altered lineage commitment in T cell receptor/CD4-transgenic mice.
    Lieberman SA; Spain LM; Wang L; Berg LJ
    Cell Immunol; 1995 Apr; 162(1):56-67. PubMed ID: 7704911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Class I- and class II-reactive TCRs coexpressed on CD4+ T cells both trigger CD4/CD8-shared and CD4-unique functions.
    Asnagli H; Schmitt-Verhulst AM; Guimezanes A
    J Immunol; 1997 May; 158(10):4533-42. PubMed ID: 9144464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen recognition and allogeneic tumor rejection in CD8+ TCR transgenic/RAG(-/-) mice.
    Manning TC; Rund LA; Gruber MM; Fallarino F; Gajewski TF; Kranz DM
    J Immunol; 1997 Nov; 159(10):4665-75. PubMed ID: 9366389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4 and CD8 accessory molecules function through interactions with major histocompatibility complex molecules which are not directly associated with the T cell receptor-antigen complex.
    Lustgarten J; Waks T; Eshhar Z
    Eur J Immunol; 1991 Oct; 21(10):2507-15. PubMed ID: 1915555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional evidence for TCR-intrinsic specificity for MHCII.
    Parrish HL; Deshpande NR; Vasic J; Kuhns MS
    Proc Natl Acad Sci U S A; 2016 Mar; 113(11):3000-5. PubMed ID: 26831112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weak positive selection of transgenic T cell receptor-bearing thymocytes: importance of major histocompatibility complex class II, T cell receptor and CD4 surface molecule densities.
    Bogen B; Gleditsch L; Weiss S; Dembic Z
    Eur J Immunol; 1992 Mar; 22(3):703-9. PubMed ID: 1547816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analyses of the TCR repertoire of MHC class II-restricted innate CD4⁺ T cells.
    Kang BH; Min HS; Lee YJ; Choi B; Kim EJ; Lee J; Kim JR; Cho KH; Kim TJ; Jung KC; Park SH
    Exp Mol Med; 2015 Mar; 47(3):e154. PubMed ID: 25813222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast between class I and class II MHC-mediated differentiation of a CD4+CD8+ T cell line: implications for lineage commitment.
    DeKoning J; Carbone FR; Kaye J
    Int Immunol; 1995 Apr; 7(4):541-9. PubMed ID: 7547680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The activation threshold of CD4+ T cells is defined by TCR/peptide-MHC class II interactions in the thymic medulla.
    Stephen TL; Tikhonova A; Riberdy JM; Laufer TM
    J Immunol; 2009 Nov; 183(9):5554-62. PubMed ID: 19843939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular mechanisms involved in protection against influenza virus infection in transgenic mice expressing a TCR receptor specific for class II hemagglutinin peptide in CD4+ and CD8+ T cells.
    Bot A; Casares S; Bot S; von Boehmer H; Bona C
    J Immunol; 1998 May; 160(9):4500-7. PubMed ID: 9574556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term persistence of CD4(+) but rapid disappearance of CD8(+) T cells expressing an MHC class I-restricted TCR of nanomolar affinity.
    Engels B; Chervin AS; Sant AJ; Kranz DM; Schreiber H
    Mol Ther; 2012 Mar; 20(3):652-60. PubMed ID: 22233579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.